Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid... see more

Bullboard (OTCPK:TRPXY)

View:
Comment by edmedon Mar 26, 2019 2:18pm

RE:News

I hope these guys know what they are doing.
Post by Fundy13on Mar 20, 2019 3:40pm

News

At least we have a NR out, much to do about nothing at this point, but never hurts to have more connections through this new consultant.  Could already be something in the works and he is being ...more  
Comment by Fundy13on Mar 15, 2019 7:31am

RE:RE:RE:Cure Pharma

I do not see any evidence that this is true
Comment by easyas123on Mar 14, 2019 10:14pm

RE:RE:Cure Pharma

Just read on FSD page that TRPX has hired Rupert Haynes as a consultant. Very interesting.
Comment by Fundy13on Mar 14, 2019 4:43pm

RE:Cure Pharma

We are getting close tot he three month mark since the HUGE deal was terminated.  Would be nice to hear an update of some sort soon.  I have predicted since Dec that we would hear somethign ...more  
Post by easyas123on Mar 13, 2019 2:49pm

Cure Pharma

Anyone keeping tabs on Cure Pharma, market cap sitting at $115M. A merger with TRPX could make a lot more sense at these prices.
Comment by easyas123on Mar 06, 2019 11:14am

RE:RE:Nice movement

With the AGM tomorrow, does anyone think we will get news beforehand?
Comment by edmedon Feb 26, 2019 5:27pm

RE:Nice movement

I'm with you Fundy lets hope its good news edmed
Post by Fundy13on Feb 26, 2019 11:27am

Nice movement

Good movement the past couple days. Deal or financing should be announced in the next 4 weeks
Comment by StuinSeaon Feb 14, 2019 7:19pm

RE:RE:I'm out.

I'm sure the PPS was weighted down by my selling today so I probably go up some. I agree they need to do something by March, and I may get back in if there is a buying opportunity before then ...more  
Comment by Fundy13on Feb 14, 2019 6:34pm

RE:I'm out.

There is always someone who sells just before things go up.  Not sure why you would hang on this long and then sell now, but I wish you good luck with your other investments.  I know I have ...more  
Post by StuinSeaon Feb 14, 2019 6:09pm

I'm out.

Still like the company just fine, but I sold my last 7k shares today as I want to use the money elsewhere. Still think TRPX is undervalued.
Comment by Fundy13on Feb 14, 2019 9:36am

RE:RE:RE:RE:RE:RE:Great Article

Good start for you.  Do I get a commision?
Comment by StuinSeaon Feb 13, 2019 4:31pm

RE:RE:RE:RE:RE:Great Article

Sold 1,999 TRPX and bought 1600 SNNVF. I could afford fewer shares of SNNVF because some of my shares of TRPX are on margin. By my selling TRPX that will make the PPS go up of course. Just filed my ...more  
Comment by Fundy13on Feb 13, 2019 3:48pm

RE:RE:RE:RE:Great Article

Almost $20million in revenue in 2018
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities